| Primary |
| Prostate Cancer |
36.6% |
| Premedication |
25.5% |
| Prostate Cancer Metastatic |
17.1% |
| Pain |
6.0% |
| Prophylaxis |
2.7% |
| Product Used For Unknown Indication |
2.4% |
| Nausea |
1.5% |
| Hypertension |
1.2% |
| Anxiety |
0.9% |
| Prostate Cancer Recurrent |
0.9% |
| Antiemetic Supportive Care |
0.6% |
| Back Pain |
0.6% |
| Breast Cancer |
0.6% |
| Chemotherapy |
0.6% |
| Constipation |
0.6% |
| Deep Vein Thrombosis |
0.6% |
| Hypersensitivity |
0.6% |
| Appetite Disorder |
0.3% |
| Bone Pain |
0.3% |
| Bronchospasm |
0.3% |
|
| Death |
22.4% |
| Disseminated Intravascular Coagulation |
7.1% |
| Pulmonary Embolism |
7.1% |
| Thrombocytopenia |
7.1% |
| Neutropenia |
6.1% |
| Gastrointestinal Haemorrhage |
5.1% |
| Ileus |
4.1% |
| Spinal Cord Compression |
4.1% |
| Chest Pain |
3.1% |
| Cold Type Haemolytic Anaemia |
3.1% |
| Diarrhoea |
3.1% |
| Disease Progression |
3.1% |
| Extravasation |
3.1% |
| Gastric Haemorrhage |
3.1% |
| Pancytopenia |
3.1% |
| Pyrexia |
3.1% |
| Respiratory Failure |
3.1% |
| Sepsis |
3.1% |
| Sudden Death |
3.1% |
| Vomiting |
3.1% |
|
| Secondary |
| Prostate Cancer |
28.4% |
| Premedication |
24.2% |
| Prostate Cancer Metastatic |
22.0% |
| Pain |
5.3% |
| Product Used For Unknown Indication |
4.4% |
| Prophylaxis |
3.1% |
| Chemotherapy |
2.7% |
| Osteoarthritis |
2.4% |
| Anxiety |
1.6% |
| Constipation |
1.6% |
| Bone Pain |
0.7% |
| Bronchospasm |
0.7% |
| Palliative Care |
0.7% |
| Vertigo |
0.7% |
| Deep Vein Thrombosis |
0.4% |
| Hypertension |
0.4% |
| Antiemetic Supportive Care |
0.2% |
| Depression |
0.2% |
| Gout |
0.2% |
| Insomnia |
0.2% |
|
| Death |
22.7% |
| Disease Progression |
7.8% |
| Gastrointestinal Haemorrhage |
7.0% |
| Pulmonary Embolism |
6.3% |
| Blood Bilirubin Increased |
4.7% |
| Chronic Obstructive Pulmonary Disease |
4.7% |
| Drug Ineffective |
4.7% |
| Prostate Cancer |
4.7% |
| Rectal Haemorrhage |
4.7% |
| Sudden Death |
4.7% |
| Asthenia |
3.1% |
| Coronary Artery Occlusion |
3.1% |
| Neutropenia |
3.1% |
| Spinal Cord Compression |
3.1% |
| Thrombocytopenia |
3.1% |
| Toxicity To Various Agents |
3.1% |
| Acute Pulmonary Oedema |
2.3% |
| Prostatic Specific Antigen Increased |
2.3% |
| Pyrexia |
2.3% |
| Vomiting |
2.3% |
|
| Concomitant |
| Metastases To Bone |
33.3% |
| Prostate Cancer Metastatic |
33.3% |
| Bone Disorder |
20.0% |
| Prophylaxis |
6.7% |
| Prostate Cancer |
6.7% |
|
| Osteonecrosis Of Jaw |
33.3% |
| Accidental Overdose |
11.1% |
| Dyspnoea |
11.1% |
| General Physical Condition Abnormal |
11.1% |
| Lacrimation Increased |
11.1% |
| Lethargy |
11.1% |
| Pyonephrosis |
11.1% |
|
